CervoMed Inc. (CRVO) Deep Dive Video

Summary

CervoMed is a deeply speculative but highly asymmetric clinical call option on neflamapimod becoming the first meaningful disease-modifying therapy for biomarker-selected dementia with Lewy bodies.

View CRVO stock page · Read the CRVO research report

Loading the video player…